ATHEM L.L.C.

MORRISVILLE, NC · Medtech · Private

Portable device that purifies therapeutic antibodies directly from whole blood using magnetic chromatography media coated with Protein A

athembio.com →
Grants
$1.3M
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Medical Device to Isolate and Purify Therapeutic Antibodies from Recovered Donors (COVID-19)$255,943
Federal grantNational Science Foundation · Phase II · SBIR Phase II: A Bioprocessing System to Isolate and Purify Therapeutic Antibodies Directly from Cell Culture.$999,998
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2257Cell-Safe Life Sciences LLC——
2258i2C Solutions, LLC——
2259FEMTOVOX INCORPORATED——
2260ATHEM L.L.C.——
2261OMNISCIENT IMAGING INC——
2262IMMUNOSHIELD THERAPEUTICS INC.——
2263Mercury Biomed LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.